000 01433 a2200397 4500
005 20250513055427.0
264 0 _c19940825
008 199408s 0 0 eng d
022 _a0021-9738
024 7 _a10.1172/JCI117407
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSanan, D A
245 0 0 _aApolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.
_h[electronic resource]
260 _bThe Journal of clinical investigation
_cAug 1994
300 _a860-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAlzheimer Disease
_xmetabolism
650 0 4 _aAmyloid beta-Peptides
_xchemistry
650 0 4 _aApolipoprotein E3
650 0 4 _aApolipoprotein E4
650 0 4 _aApolipoproteins E
_xchemistry
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aMicroscopy, Electron
700 1 _aWeisgraber, K H
700 1 _aRussell, S J
700 1 _aMahley, R W
700 1 _aHuang, D
700 1 _aSaunders, A
700 1 _aSchmechel, D
700 1 _aWisniewski, T
700 1 _aFrangione, B
700 1 _aRoses, A D
773 0 _tThe Journal of clinical investigation
_gvol. 94
_gno. 2
_gp. 860-9
856 4 0 _uhttps://doi.org/10.1172/JCI117407
_zAvailable from publisher's website
999 _c8039669
_d8039669